Also trades as: INDV.L (LSE) · $vol 5M
INDV NASDAQ
Indivior Pharmaceuticals Inc
1W: -3.4%
1M: +14.1%
3M: +7.7%
YTD: +3.5%
1Y: +226.2%
3Y: +95.5%
5Y: +242.5%
$37.59
+0.60 (+1.62%)
After Hours: $38.25 (+0.66, +1.76%)
Weekly Expected Move ±5.8%
$33
$35
$37
$39
$41
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$0.2M
Congress—
ETF Holdings—
Key Statistics
Market Cap$4.7B
52W Range11.08-41
Volume2,600,729
Avg Volume2,643,762
Beta1.20
Dividend—
Analyst Ratings
Company Info
CEOJoseph J. Ciaffoni
Employees1,030
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2014-12-29
Websiteindivior.com
10710 Midlothian Turnpike
North Chesterfield, VA 23235
US
North Chesterfield, VA 23235
US
804 379 1090
About Indivior Pharmaceuticals Inc
Indivior Pharmaceuticals Inc is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.
Latest News
TGTX Stock Rises 29% in 3 Months: Here's What You Should Know
ERNA Stock Shoots Up 140% in a Month: Here's What You Should Know
FDA Accepts IBRX's Filing Seeking Expanded Use of Bladder Cancer Therapy
New Studies Show Adherence to Monthly Injectable Buprenorphine is Associated with Relapse Reduction and Lower Healthcare Utilization
Can Encompass Health's Expansion Strategy Make It a Hold for Now?
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Thompson Juliet | A-Award | 6,518 | — | 2026-05-13 |
| Humphreys Keith | A-Award | 6,518 | — | 2026-05-13 |
| Kingsley Stuart A | A-Award | 6,518 | — | 2026-05-13 |
| NINIVAGGI DANIEL A | A-Award | 6,518 | — | 2026-05-13 |
| Ryan Barbara | A-Award | 6,518 | — | 2026-05-13 |